These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21283614)

  • 21. Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique.
    Semá Baltazar C; Rafael F; Langa JPM; Chicumbe S; Cavailler P; Gessner BD; Pezzoli L; Barata A; Zaina D; Inguane DL; Mengel MA; Munier A
    PLoS One; 2018; 13(10):e0198592. PubMed ID: 30281604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mass vaccination with a two-dose oral cholera vaccine in a long-standing refugee camp, Thailand.
    Phares CR; Date K; Travers P; Déglise C; Wongjindanon N; Ortega L; Bhuket PR
    Vaccine; 2016 Jan; 34(1):128-33. PubMed ID: 26549363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sociocultural determinants of anticipated oral cholera vaccine acceptance in three African settings: a meta-analytic approach.
    Sundaram N; Schaetti C; Merten S; Schindler C; Ali SM; Nyambedha EO; Lapika B; Chaignat CL; Hutubessy R; Weiss MG
    BMC Public Health; 2016 Jan; 16():36. PubMed ID: 26762151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventing cholera in India: Synthesizing evidences through a systematic review for policy discussion on the use of oral cholera vaccine.
    Panda S; Chatterjee P; Deb A; Kanungo S; Dutta S
    Vaccine; 2020 Feb; 38 Suppl 1():A148-A156. PubMed ID: 31405636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholera vaccine: new preventive tool for endemic countries.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2012 May; 8(5):682-4. PubMed ID: 22634452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia.
    Teshome S; Desai S; Kim JH; Belay D; Mogasale V
    Hum Vaccin Immunother; 2018; 14(10):2427-2433. PubMed ID: 29648523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed second dose of oral cholera vaccine administered before high-risk period for cholera transmission: Cholera control strategy in Lusaka, 2016.
    Ferreras E; Matapo B; Chizema-Kawesha E; Chewe O; Mzyece H; Blake A; Moonde L; Zulu G; Poncin M; Sinyange N; Kasese-Chanda N; Phiri C; Malama K; Mukonka V; Cohuet S; Uzzeni F; Ciglenecki I; Danovaro-Holliday MC; Luquero FJ; Pezzoli L
    PLoS One; 2019; 14(8):e0219040. PubMed ID: 31469853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh.
    Khan IA; Saha A; Chowdhury F; Khan AI; Uddin MJ; Begum YA; Riaz BK; Islam S; Ali M; Luby SP; Clemens JD; Cravioto A; Qadri F
    Vaccine; 2013 Dec; 31(51):6058-64. PubMed ID: 24161413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011.
    Date KA; Vicari A; Hyde TB; Mintz E; Danovaro-Holliday MC; Henry A; Tappero JW; Roels TH; Abrams J; Burkholder BT; Ruiz-Matus C; Andrus J; Dietz V
    Emerg Infect Dis; 2011 Nov; 17(11):2105-12. PubMed ID: 22099114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving community coverage of oral cholera mass vaccination campaigns: lessons learned in Zanzibar.
    Schaetti C; Ali SM; Chaignat CL; Khatib AM; Hutubessy R; Weiss MG
    PLoS One; 2012; 7(7):e41527. PubMed ID: 22844489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The case for ring vaccinations with special consideration of oral cholera vaccines.
    Deen J; von Seidlein L
    Hum Vaccin Immunother; 2018; 14(8):2069-2074. PubMed ID: 29630444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings.
    Hsiao A; Desai SN; Mogasale V; Excler JL; Digilio L
    Bull World Health Organ; 2017 Apr; 95(4):303-312. PubMed ID: 28479625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress and Challenges in Using Oral Cholera Vaccines to Control Outbreaks: The Médecins Sans Frontières Experience.
    Ciglenecki I; Azman AS; Jamet C; Serafini M; Luquero FJ; Cabrol JC
    J Infect Dis; 2018 Oct; 218(suppl_3):S165-S166. PubMed ID: 30239901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential for Controlling Cholera Using a Ring Vaccination Strategy: Re-analysis of Data from a Cluster-Randomized Clinical Trial.
    Ali M; Debes AK; Luquero FJ; Kim DR; Park JY; Digilio L; Manna B; Kanungo S; Dutta S; Sur D; Bhattacharya SK; Sack DA
    PLoS Med; 2016 Sep; 13(9):e1002120. PubMed ID: 27622507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: a matched case-control study.
    Malembaka EB; Bugeme PM; Hutchins C; Xu H; Hulse JD; Demby MN; Gallandat K; Saidi JM; Rumedeka BB; Itongwa M; Tshiwedi-Tsilabia E; Kitoga F; Bodisa-Matamu T; Kavunga-Membo H; Bengehya J; Kulondwa JC; Debes AK; Taty N; Lee EC; Lunguya O; Lessler J; Leung DT; Cumming O; Okitayemba PW; Mukadi-Bamuleka D; Knee J; Azman AS
    Lancet Infect Dis; 2024 May; 24(5):514-522. PubMed ID: 38246191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy.
    Hashim R; Khatib AM; Enwere G; Park JK; Reyburn R; Ali M; Chang NY; Kim DR; Ley B; Thriemer K; Lopez AL; Clemens JD; Deen JL; Shin S; Schaetti C; Hutubessy R; Aguado MT; Kieny MP; Sack D; Obaro S; Shaame AJ; Ali SM; Saleh AA; von Seidlein L; Jiddawi MS
    PLoS Negl Trop Dis; 2012; 6(7):e1743. PubMed ID: 22848772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing alternative cholera vaccination strategies in Maela refugee camp: using a transmission model in public health practice.
    Havumaki J; Meza R; Phares CR; Date K; Eisenberg MC
    BMC Infect Dis; 2019 Dec; 19(1):1075. PubMed ID: 31864298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innovative vaccine delivery strategies in response to a cholera outbreak in the challenging context of Lake Chilwa. A rapid qualitative assessment.
    Heyerdahl LW; Ngwira B; Demolis R; Nyirenda G; Mwesawina M; Rafael F; Cavailler P; Bernard Le Gargasson J; Mengel MA; Gessner BD; Guillermet E
    Vaccine; 2018 Oct; 36(44):6491-6496. PubMed ID: 29126808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study.
    Franke MF; Ternier R; Jerome JG; Matias WR; Harris JB; Ivers LC
    Lancet Glob Health; 2018 Sep; 6(9):e1028-e1035. PubMed ID: 30103980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of a cholera rapid diagnostic test during a mass vaccination campaign in response to an epidemic in Guinea, 2012.
    Martinez-Pino I; Luquero FJ; Sakoba K; Sylla S; Haile M; Grais RF; Ciglenecki I; Quilici ML; Page AL
    PLoS Negl Trop Dis; 2013; 7(8):e2366. PubMed ID: 23967359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.